Clinical trial
Drugs to Reduce the Side Effects of Chemotherapy
NCT00003213 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003213 |
|---|---|
| Title | Drugs to Reduce the Side Effects of Chemotherapy |
| Official title | A Randomized, Double-Blind Trial to Compare the Clinical Efficacy and Safety of Granisetron vs. Metoclopramide Combined to Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | dexamethasone, granisetron hydrochloride, metoclopramide hydrochloride |
| Enrollment | 267 |
| Start date | May 1, 1996 |
| Primary completion | Apr 1, 1999 |
| Completion | Aug 1, 1999 |
| First posted | Aug 2, 2004 |
| Last update posted | Jul 11, 2012 |
| Countries | Italy, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: